[{
  "type": "article-journal",
  "title": "PRODUCTION OF GOAT POX VIRUS VACCINE FROM A LIVE ATTENUATED GOAT POX VIRUS STRAIN",
  "author": [
    {
      "family": "Abbas",
      "given": ""
    },
    {
      "family": "Khan",
      "given": ""
    },
    {
      "family": "Hussain",
      "given": ""
    },
    {
      "family": "Ahmed",
      "given": ""
    },
    {
      "family": "Ahmed",
      "given": ""
    },
    {
      "family": "Ahmed",
      "given": ""
    },
    {
      "family": "Ahmed",
      "given": ""
    },
    {
      "family": "Attique",
      "given": ""
    },
    {
      "family": "Wadood",
      "given": ""
    },
    {
      "family": "Taj.",
      "given": ""
    }
  ],
  "issued": {
    "date-parts": [[2010]]
  },
  "container-title": "Journal of Animal and Plant Sciences",
  "ISSN": "1018-7081",
  "volume": "20",
  "issue": "4",
  "page": "315-317",
  "DOI": "NA",
  "abstract": "<p>Kid kidney cells form less than 2 months of age were grown, 80% confluent monolayers were obtained after 10-12 days.&nbsp; &nbsp;Live attenuated goat pox virus vaccine (Gorgan 55, Iranian) was used to infect the confluent monolayers.&nbsp; &nbsp;Eighty percent cytopethic effect (CPE) was obtained on day 5 of virus inoculation.&nbsp; TCID50 calculated for the pool virus was 10 5.5/ ml.&nbsp; Vaccine was found free from any bacterial and mycoplasma contamination. All mice and guinea pigs were found healthy after 21days post vaccinal administration.&nbsp; Vaccinated goats challenged after 14 days with 1 ml of virulent goat pox virus (TCID50 104.5/ml) did not show any unwanted reaction while controls challenged with 1 ml of virulent goat pox virus (TCID50 10 3.5/ml)&nbsp; showed pox lesions and rise in body temperature. The main objective of this study was to produce and study the efficacy of this vaccine.</p>",
  "publisher": "Pakistan Agricultural Scientists Forum",
  "URL": "https://thejaps.org.pk/AbstractView.aspx?mid=2010-JAPS-411"
}]